FindTrial
Sign In

Knowledge, Attitudes, and Practices in the Initiation and Optimization of Treatment for Newly Diagnosed Type 2 Diabetes Mellitus Patients with Elevated HbA1c ~9%

A Cross-Sectional Survey Assessing Physicians Knowledge, Attitudes, and Practices in the Initiation and Optimization of Treatment for Newly Diagnosed Type 2 Diabetes Mellitus Patients with Elevated HbA1c approximately 9% - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/06/112916
Enrollment
300
Registered
2026-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Dr. Reddys Laboratories Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthcare professionals practicing in India MBBS (with Diploma in Diabetology) or MD (Medicine) Minimum 5 years (post-MBBS) experience in managing diabetes

Exclusion criteria

Exclusion criteria: Not willing to participate or provide informed consent

Design outcomes

Primary

MeasureTime frame
Assessment of healthcare professionals awareness perceptions and real world clinical practices regarding treatment intensification in patients with T2DM inadequately controlled on dual oral antidiabetic therapy (HbA1c ~9%) including guideline adherence, therapeutic decision-making use of combination therapies patient adherence considerations and barriers or facilitators influencing treatment optimizationTimepoint: Day 1—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Simran Chhatwal

Dr. Reddys Laboratories Limited

simranchhatwal@drreddys.com9582711359

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026